Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

ZN-c5

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Zentalis Pharma

Drug class:

Selective estrogen receptor degrader

Related drugs:

ER positive	HER2 Negative Breast Cancer	ER positive	HER2 Negative Breast Cancer	ZN-c5 Sensitive: C2 – Inclusion Criteria ZN-c5 Sensitive : C2	ZN-c5 Sensitive: C2 – Inclusion Criteria ZN-c5 Sensitive : C2
ER Y537S	Breast Cancer	ER Y537S	Breast Cancer	ZN-c5 Sensitive: D – Preclinical ZN-c5 Sensitive : D	ZN-c5 Sensitive: D – Preclinical ZN-c5 Sensitive : D
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	ZN-c3 + ZN-c5 Sensitive: D – Preclinical ZN-c3 + ZN-c5 Sensitive : D	ZN-c3 + ZN-c5 Sensitive: D – Preclinical ZN-c3 + ZN-c5 Sensitive : D